Biopep Contracts With BRI Biopharmaceuticals Research Inc

In preparation for our FDA submission for Phase I Human Trials, Biopep is excited to report that we have contracted with BRI Biopharmaceuticals Research Inc. to further analyze the intrinsic qualities of LSE.

This study will include an in-depth analysis of:

  • LSE drug consistency
  • LSE drug efficacy including protein marker selection
  • LSE drug safety including immunotoxicity studies
  • Chemistry, manufacturing and controls of drug substance
  • Establishment of an Aquatic Vivarium and Leeches Husbandry
Biopeps News & Updates
About Webmaster